Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
DVAXDynavax Technologies	$1.76bn	295.24	n/a
VIRVir Biotechnology	$1.73bn	n/a	n/a
RAPTRapt Therapeutics	$1.68bn	n/a	n/a
BHVNBiohaven	$1.65bn	n/a	n/a
MBXMBX Biosciences	$1.60bn	n/a	n/a
DMRADamora Therapeutics	$1.60bn	n/a	n/a
IOVAIovance Biotherapeutics	$1.59bn	n/a	n/a
GLUEMonte Rosa Therapeutics	$1.58bn	n/a	n/a
ARDXArdelyx	$1.58bn	n/a	n/a
BCAXBicara Therapeutics	$1.57bn	n/a	n/a
VRDNViridian Therapeutics	$1.51bn	n/a	n/a
IMTXImmatics NV	$1.50bn	n/a	n/a
ATAIAtaiBeckley	$1.47bn	n/a	n/a
OLMAOlema Pharmaceuticals	$1.47bn	n/a	n/a
NVAXNovavax	$1.44bn	2.62	n/a
WVEWave Life Sciences	$1.41bn	n/a	n/a
CRVSCorvus Pharmaceuticals	$1.41bn	n/a	n/a
OCSOculis Holding AG	$1.40bn	n/a	n/a
MAZEMaze Therapeutics	$1.40bn	n/a	n/a
PNTPOINT Biopharma Global	$1.33bn	14.99	n/a